Asthma-associated factors - Potential predictive markers for patients stratification, personalized treatments and prevention

Liudmyla Petrenko (Kyiv, Ukraine), Rostyslav Bubnov, Liudmyla Petrenko

Source: International Congress 2016 – Asthma points to ponder
Session: Asthma points to ponder
Session type: Poster Discussion
Number: 3366
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Liudmyla Petrenko (Kyiv, Ukraine), Rostyslav Bubnov, Liudmyla Petrenko. Asthma-associated factors - Potential predictive markers for patients stratification, personalized treatments and prevention. Eur Respir J 2016; 48: Suppl. 60, 3366

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Identifying patients at risk for future exacerbations of asthma: Development of a prediction model
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015

Novel proteomic biomarkers in the evaluation of childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

A follow-up of patients with a new diagnosis of asthma - characteristics, prognosis and risk factors
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013

A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013


International perspectives on severe asthma: Current and future challenges in patient care
Source: International Congress 2016 – Asthma points to ponder
Year: 2016

Positive bronchodilator response is a poor predictor of future risk in well controlled asthma patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016

ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013

What is important to people with asthma: Maximising research impact?
Source: International Congress 2015 – Any news from the asthma field?
Year: 2015


Allergen specific immunotherapy: Effect on immunological markers and clinical outcomes in asthmatic children
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016


The potential role of bronchial challenge testing to identify overtreatment of community managed asthma
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014

U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013



Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3
Source: International Congress 2016 – Phenotyping asthma
Year: 2016

4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


A new clinically relevant method of calculating adherence
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015

Functional Respiratory Imaging as a sensitive biomarker to assess therapeutic interventions in lung diseases
Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles
Year: 2015

Bronchial asthma (BA) pharmacogenetic profile and therapeutic resistance in slavic population
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013



Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Metrics of salbutamol use as predictors of future adverse outcomes in asthma
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013


Study the role of eNO-synthasegene polymorphism in patients with asthma and obesity
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016

Assessing asthma risk in primary care: Can the AAA test predict future asthma attacks?
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014